Abstract: Techniques for managing an application token may include providing, by a first service provider application on a communication device to a first service provider computer, a first request for a first application token, receiving, by an account management application on the communication device from a token service computer in communication with the first service provider computer, the first application token, and storing the first application token in a token container in the account management application.

Abstract: A load bearing flexible conduit system (10) for use in a body of water and adapted for deployment from a reel (100) located on a water going vessel into the body of water is disclosed. The system comprises a number of lengths (12) of load bearing flexible conduit, each length of load bearing flexible conduit provided with an inner layer (44) having a throughbore and a load bearing outer layer (50). A joint (30) for connecting the lengths together has a body having a longitudinal axis and a throughbore and at least one flexible coupling to permit at least one of the said one ends of the respective first and second lengths of load bearing flexible conduit to move relative to the longitudinal axis of the joint. The lengths of load bearing flexible conduit are sufficiently flexible such that they are capable of being stored, prior to use, on a reel (100) and are further capable of being at least partially payed out from the reel into the body of water during use.

Abstract: The present disclosure relates to anti-IL-27 antibodies, and antigen-binding portions thereof. The disclosure also relates to methods for treating or ameliorating one or more symptoms of a disease, such as cancer, by administering the antibodies or antigen-binding portion thereof. The disclosure also relates to methods for detecting IL-27 in, for example, a subject or a sample.

Abstract: Disclosed herein are anti-CD47 antibody molecules, their manufacture and use in treating disorders associated with CD47 expression, for example, certain hematological cancers and solid tumors.

Abstract: A spacer for adjusting the width between rollers of roller tooling for machines operable to form metal products has an annular male member with lateral bosses and an annular female member having different depth pockets accommodating the bosses to adjust the combined width of the male and female members.

Abstract: The present invention provides a stabilising composition, comprising: a) a first phenolic antioxidant comprising one or more phenolic compounds having the structure of formula (I) wherein R1 is a linear or branched alkyl group having from 12 to 20 carbon atoms; and b) one or more second phenolic antioxidants independently selected from: a mono-hydroxybenzene having lower steric hindrance than the first phenolic antioxidant; a di-hydroxybenzene; and/or a tri-hydroxybenzene.

Abstract: A kit including a central adaptor (10) and interchangeable terminators (40) that are configured to connect two separate lines via the central adaptor (10) is described. The central adaptor (10) comprises two end connectors (20) onto which first and second terminators (40) are coupled, and the first and second lines are then coupled to the respective terminators (40) such that the lines are in fluid communication with each other. The lines may be of different diameters. The terminators (40) contained within the kit comprise a range of diameters, thereby facilitating connection of a respective range of lines.

Abstract: The present invention provides the use of a stabilising composition for stabilising a polyol and/or a polyurethane, the stabilising composition comprising: a phenolic antioxidant; and one or more phosphite antioxidants having the structure of formula (I): wherein R1, R2 and R3 are independently selected alkylated aryl groups of the structure formula (II): wherein R4, R5 and R6 are independently selected from the group consisting of hydrogen and C1 to C6 alkyl, provided that at least one of R4, R5 and R6 is not hydrogen.

Abstract: Disclosed herein are anti-CD47 antibody molecules, their manufacture and use in treating disorders associated with CD47 expression, for example, certain hematological cancers and solid tumors.

Abstract: Disclosed herein are anti-CD47 antibody molecules, their manufacture and use in treating disorders associated with CD47 expression, for example, certain hematological cancers and solid tumors.

Abstract: There is provided a stabilizing composition for hot melt adhesives, the composition comprising: a first stabilizing component comprising at least one phenolic antioxidant; a second stabilizing component comprising at least one phosphite antioxidant; and a third stabilizing component comprising at least one antioxidant containing a sulphur group having the formula —CH2-(S)x-CH2-, wherein x=1 or 2, and wherein neither of the —CH2- groups is directly bonded to an aromatic group.

Abstract: Disclosed herein are anti-CD47 antibody molecules, their manufacture and use in treating disorders associated with CD47 expression, for example, certain hematological cancers and solid tumors.

Abstract: Antigenic peptides that bind to MHC Class II molecules with the shared epitope referred to as HLA-DR molecules are disclosed. More specifically, are citrullinated antigenic peptides having an increased affinity for HLA-DR molecules and associated with rheumatoid arthritis. These novel peptides provide the basis for new methods of diagnosis and treatment of rheumatoid arthritis.

Abstract: A spacer for adjusting the width between rollers of roller tooling for machines operable to form metal products has an annular male member with lateral bosses and an annular female member having different depth pockets accommodating the bosses to adjust the combined width of the male and female members.

Abstract: Disclosed herein are anti-CD47 antibody molecules, their manufacture and use in treating disorders associated with CD47 expression, for example, certain hematological cancers and solid tumors.

Abstract: Disclosed herein are anti-CD47 antibody molecules, their manufacture and use in treating disorders associated with CD47 expression, for example, certain hematological cancers and solid tumors.

Abstract: The invention provides a stabilising composition for polymeric materials comprising: at least one secondary arylamine having the formula I: wherein: the or each R, which may be the same or different, independently denotes an optionally substituted hydrocarbyl group having at least 5 carbon atoms; x and y are each independently from 0 to 5 provided that at least one of x and y is at least 1; and a phenolic antioxidant, the composition and/or the secondary arylamine being a liquid at ambient conditions substantially free from diphenylamine and/or from lower alkylated diphenylamine antioxidants.

Abstract: The present invention relates to stabilising compositions, particularly stabilising compositions which can be used to stabilise insulation or semi-conductive compositions, such as are used for electrically insulating wires and cables. The stabilising composition comprises: a first stabilising component comprising at least one fully hindered phenolic antioxidant; a second stabilising component comprising at least one partially hindered phenolic antioxidant; and a third stabilising component comprising at least one sulphur-containing antioxidant.